🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The current trial "A Phase I/II study of Erlotinib +/- Tivozanib as initial...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01728181
Treatments Being Tested
Randomized, double-blind, 2-arm crossover study comparing tivozanib hydroch...
Status
Terminated
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01673386
This is a Phase 3, open-label, randomized, controlled, multi-national, mult...
Status
Completed
Location
University Of UA Cancer Center(UACC)/DH-SJHMC
Start Date
2016-05-24
Trial ID
NCT02627963
Treatments Being Tested
This is a phase 2 multicenter, double-blind, randomized, placebo-controlled...
Status
Terminated
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT01745367
Treatments Being Tested
This Phase 1, open-label, single dose study is designed to evaluate the pha...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01631097
Treatments Being Tested
Open-label, multi-center extension treatment protocol to allow access to ti...
Status
Completed
Location
Site 185
Start Date
2010-03
Trial ID
NCT01076010
This research study is evaluating a drug called tivozanib as a possible tre...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2013-11
Trial ID
NCT01972516
Treatments Being Tested